Arbutus Biopharma Corporation ABUS Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets?
- Arbutus Biopharma Corporation (ABUS) reported increase (decrease) in prepaid expense and other assets of $195K in Q1 2026.
- How has Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets increased by 147.2% year-over-year, from -$413K to $195K.
- What is the long-term trend for Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Arbutus Biopharma Corporation's increase (decrease) in prepaid expense and other assets has grown at a -16.4% compound annual growth rate (CAGR), from -$2.43M to -$1.7M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.